Ceftriaxone Sodium Injection, Powder, For Solution
NDC Package 71205-710-01
Package Information
Ceftriaxone Sodium injection is ceftriaxone is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Proficient Rx Lp, this product is identified by NDC 71205-710 and is authorized under FDA application ANDA065169.
Identification & Billing
- RxCUI: 1665046 - cefTRIAXone 2 GM Injection
- RxCUI: 1665046 - ceftriaxone 2000 MG Injection
- RxCUI: 1665046 - ceftriaxone 2 GM (as ceftriaxone sodium) Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 71205 - Proficient Rx Lp
- 71205-710 - Ceftriaxone Sodium
- 71205-710-01 - 1 VIAL, SINGLE-USE in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
- 71205-710 - Ceftriaxone Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71205-710-01 identifies a specific commercial package of 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use of Ceftriaxone Sodium, a human prescription drug labeled by Proficient Rx Lp. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains ceftriaxone sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Proficient Rx Lp on May 09, 2005. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Ceftriaxone is used to treat a wide variety of bacterial infections. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This drug is not recommended for use in newborns with high blood bilirubin levels and premature infants due to increased risk of side effects. Ask the doctor or pharmacist for details.
How is this Proficient Rx Lp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71205071001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.